The World Health Organization (WHO) and its partnership members including the vaccine partnership, Gavi, said the goal is to produce 2 billion doses of Covid-19 vaccines by 2021. Union Health Minister Dr. Harsh Vardhan recently attended a Covax facility session to look together to find a new coronavirus vaccine.
It may be noted that the Covax facility which Gavi launched earlier in June is a financial forum for the production of Covid-19 vaccines. The facility essentially acts as an insurance policy that will improve chances of successfully delivering COVID-19 doses of vaccines, even though some fail. This also means that there would be enough doses to go around, initially to cover several of the highest-risk classes, even some who otherwise might not be able to afford this — particularly poor and developing countries.
In North America three vaccines are being made, an equal number in Europe and in the Asia-Pacific region. It should be remembered that six out of these nine candidates are already in clinical trials. The bare minimum goal, Dr Swaminathan said, should be for the vaccine to touch at least 20 per cent of the population of all countries.